NanoVation-GS

RPM and early exacerbations alert for optimal management of respiratory patients

Health Tech & Life Sciences
Non Active, Nov 2025 ceased to operate

Company Overview

Snapshot

Founded in March 2014 by Gregory Shuster, Hossam Haick, and Nadav Bachar, NanoVation-GS operates with 1–10 employees. The company has secured $8.76M across 7 funding rounds from 3 investors. In July 2020, NanoVation-GS received a grant from the European Union.

Business overview

NanoVation-GS is a med-tech startup focused on alleviating the suffering and reducing the financial burden associated with frequent hospitalizations for chronic respiratory patients, including those with COPD and asthma. The company develops SenseGuard™, a patient-friendly solution for monitoring respiratory conditions by measuring lung function biomarkers from effortless breathing. This technology enables disease management and early detection and treatment of exacerbations, serving markets within Digital Healthcare, Medical Devices, and Patient Remote Monitoring.

Strategic signal

In July 2021, NanoVation-GS received $5.9 million from the European Innovation Council Fund for its respiratory monitoring device. This significant funding indicates strong institutional validation of the company's SenseGuard™ technology and its potential to impact the respiratory care market, signaling a boost in its development and commercialization efforts.

Company Intelligence Q&A

What is NanoVation-GS's primary product?
NanoVation-GS develops SenseGuard™, a device designed for monitoring patients' respiratory conditions and detecting early exacerbations through effortless breathing measurements.
When was NanoVation-GS founded and by whom?
NanoVation-GS was founded in March 2014 by Gregory Shuster, Hossam Haick, and Nadav Bachar.
What significant funding did NanoVation-GS receive in July 2021?
In July 2021, NanoVation-GS received $5.9 million from the European Innovation Council Fund for its respiratory monitoring device.
What grant did NanoVation-GS secure in July 2020?
In July 2020, NanoVation-GS received a grant from the European Union, as reported by Calcalistech.com.
What was a key technology milestone for NanoVation-GS in March 2014?
In March 2014, NanoVation-GS achieved a technology milestone related to enhancing medical applications with nanomaterial-based sensing, focusing on sensors, nanotechnology, and early detection for respiratory physiological parameters.

External links